Sylvie Van-Hult

Can we predict chemo-induced hematotoxicity in elderly patients treated with pegylated liposomal doxorubicin? Results of a population-based model derived from the DOGMES phase II trial of the GINECO.

C. Leyronnas, G. Freyer, E. Hénin, 2013, Journal of geriatric oncology.

Can we predict chemo-induced hematotoxicity in elderly patients treated with pegylated liposomal doxorubicin? Results of a population-based model derived from the DOGMES phase II trial of the GINECO.

C. Leyronnas, G. Freyer, E. Hénin, 2013, Journal of geriatric oncology.